Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Nuclear Cardiology
Metadata
Title
Attenuation artifact, attenuation correction, and the future of myocardial perfusion SPECT
Authors
Bhupinder Singh
Timothy M. Bateman
James A. Case
Gary Heller
Publication date
01-03-2007
Publisher
Springer-Verlag
Published in
Journal of Nuclear Cardiology / Issue 2/2007
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI
https://doi.org/10.1016/j.nuclcard.2007.01.037

Other articles of this Issue 2/2007

Journal of Nuclear Cardiology 2/2007 Go to the issue

ASNC Information Statement

Timeliness of reporting results of nuclear cardiology procedures

Erratum

Gated blood pool tomoscintigraphy with 4-dimensional optical flow motion analysis quantifies left ventricular mechanical actiation and synchronization

Original Articles

Prevalence of misregistration between SPECT and CT for attenuation-corrected myocardial perfusion SPECT

Editorial

How serious a problem for myocardial perfusion assessment is moderate misregistration between SPECT and CT?

Original Articles

A randomized trial of exercise treadmill ECG versus stress SPECT myocardial perfusion imaging as an initial diagnostic strategy in stable patients with chest pain and suspected CAD: Cost analysis

Practical Points for Nuclear Cardiology

Pharmacologic stress myocardial perfusion imaging: A practical approach

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits